AQST Bull Call Spread Strategy
AQST (Aquestive Therapeutics, Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly; and AQST-109, an orally delivered epinephrine product candidate for the emergency treatment of allergic reactions, including anaphylaxis. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.
AQST (Aquestive Therapeutics, Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $410.1M, a beta of 1.50 versus the broader market, a 52-week range of 2.145-7.55, average daily share volume of 1.7M, a public-listing history dating back to 2018, approximately 142 full-time employees. These structural characteristics shape how AQST stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.50 indicates AQST has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a bull call spread on AQST?
A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width.
Current AQST snapshot
As of May 15, 2026, spot at $4.22, ATM IV 61.10%, IV rank 10.42%, expected move 17.52%. The bull call spread on AQST below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this bull call spread structure on AQST specifically: AQST IV at 61.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a AQST bull call spread, with a market-implied 1-standard-deviation move of approximately 17.52% (roughly $0.74 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AQST expiries trade a higher absolute premium for lower per-day decay. Position sizing on AQST should anchor to the underlying notional of $4.22 per share and to the trader's directional view on AQST stock.
AQST bull call spread setup
The AQST bull call spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AQST near $4.22, the first option leg uses a $4.22 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AQST chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AQST shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $4.22 | N/A |
| Sell 1 | Call | $4.43 | N/A |
AQST bull call spread risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit.
AQST bull call spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bull call spread on AQST. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use bull call spread on AQST
Bull call spreads on AQST reduce the cost of a bullish AQST stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
AQST thesis for this bull call spread
The market-implied 1-standard-deviation range for AQST extends from approximately $3.48 on the downside to $4.96 on the upside. A AQST bull call spread caps both the risk and the reward of a bullish position; relative to an outright long call on AQST, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current AQST IV rank near 10.42% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AQST at 61.10%. As a Healthcare name, AQST options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AQST-specific events.
AQST bull call spread positions are structurally moderately bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AQST positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AQST alongside the broader basket even when AQST-specific fundamentals are unchanged. Long-premium structures like a bull call spread on AQST are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current AQST chain quotes before placing a trade.
Frequently asked questions
- What is a bull call spread on AQST?
- A bull call spread on AQST is the bull call spread strategy applied to AQST (stock). The strategy is structurally moderately bullish: A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width. With AQST stock trading near $4.22, the strikes shown on this page are snapped to the nearest listed AQST chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are AQST bull call spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the AQST bull call spread priced from the end-of-day chain at a 30-day expiry (ATM IV 61.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AQST bull call spread?
- The breakeven for the AQST bull call spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AQST market-implied 1-standard-deviation expected move is approximately 17.52%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bull call spread on AQST?
- Bull call spreads on AQST reduce the cost of a bullish AQST stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
- How does current AQST implied volatility affect this bull call spread?
- AQST ATM IV is at 61.10% with IV rank near 10.42%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.